Showing results (41-50 of 187) with videos related to
Sort By:
Pageof 19
Journal of Autoimmunity|April 8, 2014
Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patientsAna Luisa Calich, Xavier Puéchal, Grégory Pugnet, et al.Journal of Autoimmunity|April 18, 2013
Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trialsMaxime Samson, Xavier Puéchal, Hervé Devilliers, et al.Rheumatology (Oxford, England)|June 22, 2021
Revisiting characteristics, treatment and outcome of cardiomyopathy in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss)Silvia Sartorelli, Guillaume Chassagnon, Pascal Cohen, et al.Arthritis Care & Research|May 23, 2022
Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage AccrualPaolo Delvino, Federica Sardanelli, Sara Monti, et al.Joint Bone Spine|July 6, 2010
Behçet's disease in East African patients may not be unusual and is an HLA-B51 negative condition: a case series from Mayotte (Comoros)Eric Liozon, Céline Roussin, Xavier Puéchal, et al.Arthritis Care & Research|May 18, 2011
Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sjögren's syndrome: a national multicentric retrospective studyStéphanie Rist, Jérémie Sellam, Eric Hachulla, et al.Plos One|April 16, 2011
Decreased numbers of blood dendritic cells and defective function of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitisMarie Rimbert, Mohamed Hamidou, Cécile Braudeau, et al.ACR Open Rheumatology|June 11, 2021
Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody-Associated Vasculitis: Systematic Review and Meta-AnalysisValérie Bénard, Cynthia Farhat, Melissa Zarandi-Nowroozi, et al.Autoimmunity Reviews|August 26, 2014
Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factorsMaxime Samson, Xavier Puéchal, Hervé Devilliers, et al.Medicine|October 23, 2013
Central nervous system involvement in Whipple disease: clinical study of 18 patients and long-term follow-upCaroline Compain, Karim Sacre, Xavier Puéchal, et al.Pageof 19